HDM1002
A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and Warfarin
Huadong Medicine · Phase 1 · Recruiting · Enrollment 111
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| experimental arm | Obesity or overweight | n/r | n/r | n/r | n/r |